Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening
Jose M. Silva,1
Krista Marran,1
Joel S. Parker,3
Javier Silva,1
Michael Golding,1
Michael R. Schlabach,2
Stephen J. Elledge,2
Gregory J. Hannon,1*
Kenneth Chang1
Abstract:
By virtue of their accumulated genetic alterations, tumor cellsmay acquire vulnerabilities that create opportunities for therapeuticintervention. We have devised a massively parallel strategyfor screening short hairpin RNA (shRNA) collections for stableloss-of-function phenotypes. We assayed from 6000 to 20,000shRNAs simultaneously to identify genes important for the proliferationand survival of five cell lines derived from human mammary tissue.Lethal shRNAs common to these cell lines targeted many knowncell-cycle regulatory networks. Cell line–specific sensitivitiesto suppression of protein complexes and biological pathwaysalso emerged, and these could be validated by RNA interference(RNAi) and pharmacologically. These studies establish a practicalplatform for genome-scale screening of complex phenotypes inmammalian cells and demonstrate that RNAi can be used to exposegenotype-specific sensitivities.
1 Watson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA. 2 Department of Genetics, Center for Genetics and Genomics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA. 3 Expression Analysis, Inc., 4324 South Alston Avenue, Durham, NC 27713, USA.
* To whom correspondence should be addressed. E-mail: hannon{at}cshl.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (5 February 2008) Sci. Signal.1 (5), ec50.
[DOI: 10.1126/stke.15ec50] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Network-based drug discovery by integrating systems biology and computational technologies.
E. L. Leung, Z.-W. Cao, Z.-H. Jiang, H. Zhou, and L. Liu (2012)
Brief Bioinform
|Abstract »|Full Text »|PDF »
Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential.
N. L. Solimini, Q. Xu, C. H. Mermel, A. C. Liang, M. R. Schlabach, J. Luo, A. E. Burrows, A. N. Anselmo, A. L. Bredemeyer, M. Z. Li, et al. (2012)
Science
337, 104-109
|Abstract »|Full Text »|PDF »
MicroSCALE Screening Reveals Genetic Modifiers of Therapeutic Response in Melanoma.
K. C. Wood, D. J. Konieczkowski, C. M. Johannessen, J. S. Boehm, P. Tamayo, O. B. Botvinnik, J. P. Mesirov, W. C. Hahn, D. E. Root, L. A. Garraway, et al. (2012)
Science Signaling
5, rs4
|Abstract »|Full Text »|PDF »
Development of Methods for Quantitative Comparison of Pooled shRNAs by Mass Sequencing.
H. Hoshiyama, J. Tang, K. Batten, G. Xiao, J.-M. Rouillard, J. W. Shay, Y. Xie, and W. E. Wright (2012)
J Biomol Screen
17, 258-265
|Abstract »|Full Text »|PDF »
Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells.
R. Marcotte, K. R. Brown, F. Suarez, A. Sayad, K. Karamboulas, P. M. Krzyzanowski, F. Sircoulomb, M. Medrano, Y. Fedyshyn, J. L. Y. Koh, et al. (2012)
Cancer Discovery
2, 172-189
|Abstract »|Full Text »|PDF »
OGEE: an online gene essentiality database.
W.-H. Chen, P. Minguez, M. J. Lercher, and P. Bork (2012)
Nucleic Acids Res.
40, D901-D906
|Abstract »|Full Text »|PDF »
COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines.
J. L. Y. Koh, K. R. Brown, A. Sayad, D. Kasimer, T. Ketela, and J. Moffat (2012)
Nucleic Acids Res.
40, D957-D963
|Abstract »|Full Text »|PDF »
A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer.
N. Li, S. Kaur, J. Greshock, H. Lassus, X. Zhong, Y. Wang, A. Leminen, Z. Shao, X. Hu, S. Liang, et al. (2012)
Cancer Res.
72, 154-164
|Abstract »|Full Text »|PDF »
Mammalian meiosis is more conserved by sex than by species: conserved co-expression networks of meiotic prophase.
A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis.
N. Dompe, C. S. Rivers, L. Li, S. Cordes, M. Schwickart, E. A. Punnoose, L. Amler, S. Seshagiri, J. Tang, Z. Modrusan, et al. (2011)
PNAS
108, E943-E951
|Abstract »|Full Text »|PDF »
Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets.
Y. Ding, D. Huang, Z. Zhang, J. Smith, D. Petillo, B. D. Looyenga, K. Feenstra, J. P. MacKeigan, K. A. Furge, and B. T. Teh (2011)
Cancer Res.
71, 5225-5234
|Abstract »|Full Text »|PDF »
Rapid identification of therapeutic targets in hematologic malignancies via functional genomics.
J. W. Tyner (2011)
Therapeutic Advances in Hematology
2, 83-93
|Abstract »|PDF »
Making sense of cancer genomic data.
L. Chin, W. C. Hahn, G. Getz, and M. Meyerson (2011)
Genes & Dev.
25, 534-555
|Abstract »|Full Text »|PDF »
A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration.
G. A. Smolen, J. Zhang, M. J. Zubrowski, E. J. Edelman, B. Luo, M. Yu, L. W. Ng, C. M. Scherber, B. J. Schott, S. Ramaswamy, et al. (2010)
Genes & Dev.
24, 2654-2665
|Abstract »|Full Text »|PDF »
Mouse models of cancer as biological filters for complex genomic data.
E. Oricchio, A. L. Wolfe, J. H. Schatz, K. J. Mavrakis, and H.-G. Wendel (2010)
Dis. Model. Mech.
3, 701-704
|Abstract »|Full Text »|PDF »
A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.
K. E. Hurov, C. Cotta-Ramusino, and S. J. Elledge (2010)
Genes & Dev.
24, 1939-1950
|Abstract »|Full Text »|PDF »
Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs.
M. Izumiya, K. Okamoto, N. Tsuchiya, and H. Nakagama (2010)
Carcinogenesis
31, 1354-1359
|Abstract »|Full Text »|PDF »
Highly-multiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples.
A. M. Smith, L. E. Heisler, R. P. St.Onge, E. Farias-Hesson, I. M. Wallace, J. Bodeau, A. N. Harris, K. M. Perry, G. Giaever, N. Pourmand, et al. (2010)
Nucleic Acids Res.
38, e142
|Abstract »|Full Text »|PDF »
Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma.
R. Satow, M. Shitashige, Y. Kanai, F. Takeshita, H. Ojima, T. Jigami, K. Honda, T. Kosuge, T. Ochiya, S. Hirohashi, et al. (2010)
Clin. Cancer Res.
16, 2518-2528
|Abstract »|Full Text »|PDF »
Systems-level cancer gene identification from protein interaction network topology applied to melanogenesis-related functional genomics data.
T. Milenkovic, V. Memisevic, A. K. Ganesan, and N. Przulj (2010)
J R Soc Interface
7, 423-437
|Abstract »|Full Text »|PDF »
Predicting Meiotic Pathways in Human Fetal Oogenesis.
P. Zheng, M. D. Griswold, T. J. Hassold, P. A. Hunt, C. L. Small, and P. Ye (2010)
Biol Reprod
82, 543-551
|Abstract »|Full Text »|PDF »
Quantitative cell array screening to identify regulators of gene expression.
Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo.
J. Nichols, J. Silva, M. Roode, and A. Smith (2009)
Development
136, 3215-3222
|Abstract »|Full Text »|PDF »
Identification of GAS1 as an Epirubicin Resistance-related Gene in Human Gastric Cancer Cells with a Partially Randomized Small Interfering RNA Library.
L. Zhao, Y. Pan, Y. Gang, H. Wang, H. Jin, J. Tie, L. Xia, Y. Zhang, L. He, L. Yao, et al. (2009)
J. Biol. Chem.
284, 26273-26285
|Abstract »|Full Text »|PDF »
Development of Mammary Tumors by Conditional Expression of GLI1.
M. Fiaschi, B. Rozell, A. Bergstrom, and R. Toftgard (2009)
Cancer Res.
69, 4810-4817
|Abstract »|Full Text »|PDF »
Challenges and Opportunities in Defining the Essential Cancer Kinome.
NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.
B. Wang, K. Hurov, K. Hofmann, and S. J. Elledge (2009)
Genes & Dev.
23, 729-739
|Abstract »|Full Text »|PDF »
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets.
J. M. Flanagan, J. M. Funes, S. Henderson, L. Wild, N. Carey, and C. Boshoff (2009)
Mol. Cancer Ther.
8, 249-260
|Abstract »|Full Text »|PDF »
Highly parallel identification of essential genes in cancer cells.
B. Luo, H. W. Cheung, A. Subramanian, T. Sharifnia, M. Okamoto, X. Yang, G. Hinkle, J. S. Boehm, R. Beroukhim, B. A. Weir, et al. (2008)
PNAS
105, 20380-20385
|Abstract »|Full Text »|PDF »
Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines.
D. A. Grueneberg, W. Li, J. E. Davies, J. Sawyer, J. Pearlberg, and E. Harlow (2008)
PNAS
105, 16490-16495
|Abstract »|Full Text »|PDF »
A comprehensive synthetic genetic interaction network governing yeast histone acetylation and deacetylation.
Y.-y. Lin, Y. Qi, J.-y. Lu, X. Pan, D. S. Yuan, Y. Zhao, J. S. Bader, and J. D. Boeke (2008)
Genes & Dev.
22, 2062-2074
|Abstract »|Full Text »|PDF »
Cancer Proliferation Gene Discovery Through Functional Genomics.
M. R. Schlabach, J. Luo, N. L. Solimini, G. Hu, Q. Xu, M. Z. Li, Z. Zhao, A. Smogorzewska, M. E. Sowa, X. L. Ang, et al. (2008)
Science
319, 620-624
|Abstract »|Full Text »|PDF »